These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9749102)

  • 1. [Indications for tridimensional conformal radiotherapy in cancer of the prostate].
    Bolla M
    Cancer Radiother; 1998; 2(1):79-80. PubMed ID: 9749102
    [No Abstract]   [Full Text] [Related]  

  • 2. [New methods in the treatment of localized prostate cancer: use of dynamic arc therapy and kV cone-beam CT positioning].
    Szappanos S; Farkas R; Lőcsei Z; László Z; Kalincsák J; Bellyei S; Sebestyén Z; Csapó L; Sebestyén K; Halász J; Musch Z; Beöthe T; Farkas L; Mangel L
    Orv Hetil; 2014 Aug; 155(32):1265-72. PubMed ID: 25087218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
    Sandler HM
    Front Radiat Ther Oncol; 1996; 29():238-43. PubMed ID: 8742904
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2].
    Wiltshire K; Bristow RG; Warde P; Gospodarowicz M
    Radiother Oncol; 2004 Nov; 73(2):252-4; author reply 254-5. PubMed ID: 15542174
    [No Abstract]   [Full Text] [Related]  

  • 5. Three dimensional conformal neutron radiotherapy for prostate cancer.
    Chuba PJ; Maughan R; Forman JD
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():79-81. PubMed ID: 10394405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better?
    Schellhammer PF
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):489-90. PubMed ID: 9635693
    [No Abstract]   [Full Text] [Related]  

  • 7. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
    Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center.
    Leibel SA; Kutcher GJ; Zelefsky MJ; Burman CM; Mohan R; Ling CC; Fuks Z
    Front Radiat Ther Oncol; 1996; 29():229-37. PubMed ID: 8742903
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenge for conformal therapy for prostate cancer.
    Beard CJ; Kaplan ID; Coleman CN
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):705-7. PubMed ID: 8331005
    [No Abstract]   [Full Text] [Related]  

  • 11. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
    Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curative radiotherapy of localized prostate cancer. Treatment methods and results].
    Schwarz R
    Urologe A; 2003 Sep; 42(9):1212-20. PubMed ID: 14504754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration.
    Horsley PJ; Aherne NJ; Edwards GV; Benjamin LC; Wilcox SW; McLachlan CS; Assareh H; Welshman R; McKay MJ; Shakespeare TP
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):15-21. PubMed ID: 25227727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should the seminal vesicles be included in the target volume in prostate radiotherapy?
    Bayman NA; Wylie JP
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large rectal cross section might be more than distention.
    Petersen J
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):329. PubMed ID: 16377422
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
    Al-Salihi O; Mitra A; Payne H
    Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of Rectal Distension Seen on Prostate Radiotherapy Planning CT Scan Is Not a Negative Prognostic Factor in the Modern Era of Image-Guided Radiotherapy.
    Silverman R; Johnson K; Perry C; Sundar S
    Oncology; 2016; 90(1):51-6. PubMed ID: 26540171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
    Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
    Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal radiotherapy to the prostate: are bigger fields better?
    Hoskin PJ
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):296-7. PubMed ID: 12206641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostate cancer].
    Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.